Biotechnology Stocks I Performance Guide: Royalty Pharma plc (RPRX)
RPRX's current annual dividend and dividend yield are $3.34 (12.60%)
Table and Chart of RPRX Performance
See what a $1,000 investment in RPRX is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| RPRX Returns | |
|---|---|
| Start Date | Jul-31-2020 |
| Start Price | $40.24 |
| End Date | Dec-01-2023 |
| End Price | $27.35 |
| # Prices | 42 |
| Min Date | Oct-31-2023 |
| Min Price | $26.67 |
| Max Date | Dec-31-2020 |
| Max Price | $47.13 |
| Total Return | -32.03% |
| Annualized Return | -10.45% |
| Current Value of $1,000 Purchase | $680 |
| Number Returns | 861 |
| Average Return | -9.56% |
| Number Profitable Returns | 248 |
| Percent Profitable Returns | 28.80% |
| Number Unprofitable Returns | 613 |
| Percent Unprofitable Returns | 71.20% |
| Profitable to Unprofitable Returns Ratio | 0.40 |
| RPRX Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $16,398,650,000 | Price to Sales | 7.06 |
| Earnings per Share | $0.3900 |
| PE Ratio | 70.13 |
| PE to Growth Ratio | -0.02 |
| Price to Book | 1.99 |
| PRICE DATA | |
| 52 Week High | $41.88 |
| 52 Week Low | $25.73 |
| Analyst Target Price | $48.14 |
| 50-Day Moving Average | $27.16 |
| 200-Day Moving Average | $31.35 |
| FINANCIAL DATA | |
| Revenue per Share | $5.2 |
| Revenue | $2,324,234,000 |
| Profit Margin | 7.93% |
| Return on Equity | 0.0372% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
RPRX Dollar-cost Average
RPRX Compare Returns with S&P 500
RPRX Trendline Chart